Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Pfizer

This article was originally published in The Tan Sheet

Executive Summary

Pfizer: Acquires Cortizone and Hemorid brands from Thompson Medical for an undisclosed price, the firm announced on March 1. Pfizer Exec VP Henry McKinnell, PhD, noted that, following the acquisition of Bain de Soleil sunscreens, the Cortizone itching treatment and Hemorid women's hemorrhoidal preparation brands "will significantly strengthen Pfizer Consumer Health Care's growing presence in therapeutic skin care and women's health care." Sold only in the U.S., Cortizone comes in a number of formulations including Cortizone-5, Cortizone-10 and Cortizone for Kids, and Hemorid is available as a cream, suppositories, ointment and personal cleansing lotion. The purchase does not include facilities or employees...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084845

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel